LTR Pharma Limited (ASX: LTP)
Sector: Health Care
Market cap: A$78M (as of 2 Nov 2026)
The Company is a drug development, research and repurposing company, focused on men's health and, currently, commercialising a 'first-in-class' rapid onset, on demand therapeutic nasal spray for the treatment of erectile dysfunction.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
Cash and runway
Ask about LTP in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has LTP raised money in the last year, and at what discount?
- What was LTP's latest cash position and runway?
Loading LTP…